PMC:7396557 / 84633-84755 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T887","span":{"begin":0,"end":9},"obj":"CL:0000576"},{"id":"T35788","span":{"begin":0,"end":9},"obj":"CL:0000576"}],"text":"monocytes. In addition, the SFI treatment group had a better response than the control group for duration of vasopressor a"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T472","span":{"begin":0,"end":9},"obj":"Body_part"}],"attributes":[{"id":"A472","pred":"fma_id","subj":"T472","obj":"http://purl.org/sig/ont/fma/fma62864"}],"text":"monocytes. In addition, the SFI treatment group had a better response than the control group for duration of vasopressor a"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T808","span":{"begin":0,"end":9},"obj":"http://purl.obolibrary.org/obo/CL_0000576"},{"id":"T809","span":{"begin":52,"end":53},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"monocytes. In addition, the SFI treatment group had a better response than the control group for duration of vasopressor a"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T91059","span":{"begin":42,"end":47},"obj":"Chemical"},{"id":"T297","span":{"begin":87,"end":92},"obj":"Chemical"}],"attributes":[{"id":"A62385","pred":"chebi_id","subj":"T91059","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A73319","pred":"chebi_id","subj":"T297","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"monocytes. In addition, the SFI treatment group had a better response than the control group for duration of vasopressor a"}